SCHEMBL15940200

SCHEMBL15940200

CC(C)c1cccc(C(C)C)c1-n1c(-c2ccccc2)nc2cc(-c3ccccc3)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
NLRP3 Q96P20 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
SIRT2 Q8IXJ6 2/20 0.38
SIRT1 Q96EB6 2/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE10A Q9Y233 1/20 0.37
USP30 Q70CQ3 1/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
DHODH Q02127 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15939833 0.91 ALDH1A1 (0.44) ALDH1A1ALOX15TSHRHDAC1HDAC8
SCHEMBL13299533 0.90 NLRP3 (0.52) ALDH1A1ALOX15TSHRNLRP3SIRT2
SCHEMBL18371992 0.88 ESR1 (0.43) ALDH1A1ALOX15TSHRHDAC1HDAC8
SCHEMBL15940311 0.87 NLRP3 (0.40) ALDH1A1NLRP3HDAC1HDAC8HDAC6
SCHEMBL2456142 0.86 ESR1 (0.51) ALDH1A1ALOX15TSHRESR1ESR2
SCHEMBL20458041 0.85 ALDH1A1 (0.44) ALDH1A1ALOX15TSHRNLRP3HDAC1
SCHEMBL15316051 0.85 KDM4E (0.46) ALDH1A1ALOX15TSHRESR1ESR2
SCHEMBL13299540 0.83 NLRP3 (0.51) ALDH1A1NLRP3HDAC1HDAC8HDAC6
SCHEMBL13299522 0.81 ESR1 (0.49) ALDH1A1ALOX15TSHRESR1ESR2
SCHEMBL18371991 0.81 MAPK10 (0.48) ALDH1A1TSHRHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10400163-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-03 US disclosed
US-10400163-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-03 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed
US-20140225069-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10400163-B2 Organic electroluminescent materials and devices INTS9, SRSF9, PRMT9 ALDH1A1 2082/4885ALOX15 4095/4885TSHR 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.